“Development Of A Box–Behnken Design Optimized Linagliptin Liposphere Formulation For Improved Bioavailability And Sustained Release”, JOC, vol. 24, no. 7s, pp. 866–877, Sep. 2025, doi: 10.64149/J.Carcinog.24.7s.866-877.